Hengrui Pharma Buys Back 420,000 A Shares for RMB 19.82 Million

Bulletin Express06-04 17:24

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) executed an on-market repurchase of 420,000 A shares on 4 June 2026 via the Shanghai Stock Exchange.

The shares were acquired at prices between RMB 46.70 and RMB 47.70, resulting in a total consideration of RMB 19.82 million and a volume-weighted average cost of RMB 47.20 per share. All repurchased stock has been earmarked as treasury shares for the company’s A-share employee stock-ownership schemes.

Following the transaction, the company’s issued share capital (excluding treasury shares) decreased by 0.0066 % to 6,371,685,824 shares, while treasury shares rose to 7,316,450. Total issued shares, including treasury holdings, remained unchanged at 6,379,002,274.

According to the disclosure, the buyback was duly authorised by the board and complied with all applicable listing rules and domestic regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1137034891?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 17:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137034891","market":"us","top_or_hot":-1,"title":"Hengrui Pharma Buys Back 420,000 A Shares for RMB 19.82 Million","media":"Bulletin Express","content":"<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) executed an on-market repurchase of 420,000 A shares on 4 June 2026 via the Shanghai Stock Exchange.</p>\n<p>The shares were acquired at prices between RMB 46.70 and RMB 47.70, resulting in a total consideration of RMB 19.82 million and a volume-weighted average cost of RMB 47.20 per share. All repurchased stock has been earmarked as treasury shares for the company’s A-share employee stock-ownership schemes.</p>\n<p>Following the transaction, the company’s issued share capital (excluding treasury shares) decreased by 0.0066 % to 6,371,685,824 shares, while treasury shares rose to 7,316,450. Total issued shares, including treasury holdings, remained unchanged at 6,379,002,274.</p>\n<p>According to the disclosure, the buyback was duly authorised by the board and complied with all applicable listing rules and domestic regulations.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hengrui Pharma Buys Back 420,000 A Shares for RMB 19.82 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHengrui Pharma Buys Back 420,000 A Shares for RMB 19.82 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-04 17:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) executed an on-market repurchase of 420,000 A shares on 4 June 2026 via the Shanghai Stock Exchange.</p>\n<p>The shares were acquired at prices between RMB 46.70 and RMB 47.70, resulting in a total consideration of RMB 19.82 million and a volume-weighted average cost of RMB 47.20 per share. All repurchased stock has been earmarked as treasury shares for the company’s A-share employee stock-ownership schemes.</p>\n<p>Following the transaction, the company’s issued share capital (excluding treasury shares) decreased by 0.0066 % to 6,371,685,824 shares, while treasury shares rose to 7,316,450. Total issued shares, including treasury holdings, remained unchanged at 6,379,002,274.</p>\n<p>According to the disclosure, the buyback was duly authorised by the board and complied with all applicable listing rules and domestic regulations.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01276","symbol_name":"恒瑞医药","start_time":0,"source_url":"","article_id":"1137034891","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137034891","pubTimestamp":1780565042,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) executed an on-market repurchase of 420,000 A shares on 4 June 2026 via the Shanghai Stock Exchange. The shares were acquired at prices...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01276":"恒瑞医药"},"translate_title":"恒瑞医药1982万元回购42万股A股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01276":1},"content_text":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) executed an on-market repurchase of 420,000 A shares on 4 June 2026 via the Shanghai Stock Exchange.\nThe shares were acquired at prices between RMB 46.70 and RMB 47.70, resulting in a total consideration of RMB 19.82 million and a volume-weighted average cost of RMB 47.20 per share. All repurchased stock has been earmarked as treasury shares for the company’s A-share employee stock-ownership schemes.\nFollowing the transaction, the company’s issued share capital (excluding treasury shares) decreased by 0.0066 % to 6,371,685,824 shares, while treasury shares rose to 7,316,450. Total issued shares, including treasury holdings, remained unchanged at 6,379,002,274.\nAccording to the disclosure, the buyback was duly authorised by the board and complied with all applicable listing rules and domestic regulations.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1137034891","isCrawlerRequest":true}